Update on universal annual influenza immunization recommendations for children

Current Opinion in Pediatrics

Volumn 21, Issue 1, 2009, Pages 122-126

  Bekker, Anna ^a   Chou, Courtney ^a   Bernstein, Henry H ^a  

^a CHILDREN S HOSPITAL AT DARTMOUTH   (United States)

Author keywords

Immunization; Influenza vaccine; Vaccine safety

Indexed keywords

INFLUENZA VACCINE; TRIPLE VACCINE;

CHILD; HERD IMMUNITY; HUMAN; INFANT; INFLUENZA; INFLUENZA VACCINATION; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SCHOOL CHILD; VIRUS STRAIN;

ADOLESCENT; ADVISORY COMMITTEES; CHILD; CHILD, PRESCHOOL; HEALTH PLANNING GUIDELINES; HEALTH POLICY; HUMANS; IMMUNITY, HERD; IMMUNIZATION PROGRAMS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MASS IMMUNIZATION; PEDIATRICS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME; UNITED STATES; UNIVERSAL PRECAUTIONS;

EID: 62849122605     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32832185af     Document Type: Review

References (26)

1. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004;292:1333-1340.
2. Glezen WP, Greenberg SB, Atmar RL, et al. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000;283:499-505.
3. Epperson S, Perrotta D, Fiore A. Preliminary report: consultation on routine vaccination against influenza for older children [personal communication]. Atlanta, Georgia: Centers for Disease Control and Prevention and Council of State and Territorial Epidemiologists; 10-11 September 2007. pp. 1-18.
4. National Foundation for Infectious Diseases. Public perception of influenza, vaccination and treatment options: national consumer survey sponsored by the National Foundation for Infectious Diseases (NFID). September 2006.
5. Piedra PA, Gaglani MJ, Kozinetz AA, et al. Herd immunity in adults against influenza-related illness with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005;23:1540-1548.
6. Weycker D, Edelsberg J, Halloran ME, et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005;23:1284-1293.
7. Groll DL, Thomson DJ. Incidence of influenza in Ontario following the universal influenza campaign. Vaccine 2006;23:5245-5250.
8. Center for Disease Control (CDC). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Reo 2008:57:1-59.
9. Schwarte B, Hinman A, Abramson J, et al. Universal influenza vaccination in the United States: are we ready? Report of a meeting. J Infect Dis 2006;194 (Suppl 2):S147-S154.
10. Centers for Disease Control and Prevention. Influenza activity: United States and worldwide, 2007-2008 season. MMWR Morb Mortal Wkly Rep 2008;57:692-697.
11. Belongia E, Kieke B, Coleman L, et al. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine: Marshfield, Wisconsin, 2007-08 influenza season. MMWR Morb Mortal Wkly Rep 2008;57:393-398.
12. Ashkenazi S, Vertruyen A, Aristegui J, et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006;25:870-879.
13. Jefferson T, Smith S, Demicheli V, et al. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005;365:773-780.
14. Guthrie T, Hobbs CGL, Davenport V, et al. Parenteral influenza vaccination influences mucosal and systemic T cell-mediated immunity in healthy adults. J Infect Dis 2004;190:1927-1935.
15. Forrest PD, Pride MW, Dunning AJ. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol 2008;15:1042-1053.
16. Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007;356:685-696.
17. Demicheli V, Di Pietrantonj C, Jefferson T, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2007: CD001269.
18. Vesikari T, Karvonen A, Smith HM. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age. Pediatrics 2008;121:568-573.
19. Poland G, Johnson D. Increasing influenza vaccination rates: the need to vaccinate throughout the entire influenza season. Am J Med 2008;121:S3-S7.
20. Carpenter LR, Lott J, Lawson B, et al. Mass distribution of free, intranasally administered influenza vaccine in a public school system. Pediatrics 2007;120:e172-e178.
21. Hull HF, Frauendienst RS, Gundersen ML, et al. School-based influenza immunization. Vaccine 2008;26:4312-4313.
22. Lindley MC, Boyer-Chu L, et al. The role of schools in strengthening delivery of new adolescent vaccinations. Pediatrics 2008;121 (Suppl 1):S46-S54.
23. Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007;25:5086-5096.
24. Ampofo K, Gesteland PH, Bender J, et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics 2006;118:2409-2417.
25. Salo H, Kilpi T, Sintonen H, et al. Cost-effectiveness of influenza vaccination of healthy children. Vaccine 2006;24:4934-4941.
26. Prosser LA, Bridges CB, Uyeki TM, et al. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis 2006;12:1548-1558.